Stay updated with breaking news from Shari Pilon Thomas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A first-of-its-kind cellular immunotherapy pioneered at Moffitt Cancer Center has received approval from the Food and Drug Administration and is now available f
A first-of-its-kind cellular immunotherapy pioneered at Moffitt Cancer Center has received approval from the Food and Drug Administration and is now available f
SAN DIEGO, Sept. 28, 2023 -- Turnstone Biologics Corp. , a clinical-stage biotechnology company developing new medicines to treat and cure solid tumors by pioneering a differentiated approach to...
/PRNewswire/ -- The Mark Foundation for Cancer Research announced twelve outstanding research projects to receive its latest round of ASPIRE awards. Grantees...
The results showed that most cancer patients had seroconverted, meaning they developed antibodies after receiving the vaccine. Overall, 71.3 per cent of patients seroconverted after the first dose, 90.3 per cent after the second. There were, however, differences among cancer types.